|
PRZOOM - /newswire/ -
Salt Lake City, UT, United States, 2010/04/09 - Aciont’s poster “Transscleral Passive Delivery of Rapamycin in Rabbit Using a Visulex Topical Application Device” will be shown on May 6, 2010 at the ARVO Annual Meeting.
|
|
Aciont, Inc. announced today that the company will present findings on its Visulex® rapamycin topical delivery application in a poster session at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Fort Lauderdale, FL.
The poster 5318/A246 is titled “Transscleral Passive Delivery of Rapamycin in Rabbit Using a Visulex® Topical Application Device,” which can be viewed on Thursday, May 6, 2010 from 8:30AM – 10:15AM in Hall B/C at the Greater Fort Lauderdale Convention Center. Aciont personnel will be in attendance at the ARVO meeting to respond to questions regarding Aciont’s work.
“This study demonstrates that the Visulex® device can deliver passively rapamycin, a hydrophobic drug, allowing the drug to remain in the eye tissues for at least 24 hours following treatment,” said Dr. Kongnara Papangkorn, Aciont’s Director of Research and lead author of the presentation. “A localized, non-invasive topical application device provides potentially significant patient compliance; cost savings; drug dose control and optimization; and safety advantages over oral pills and ocular injections in order to treat chronic sight threatening diseases,” Dr. Papangkorn added.
About Aciont, Inc.
Aciont, Inc. (aciont.com) is a specialty biopharmaceutical company endeavoring to become the world leader in commercializing localized, non-invasive (topical passive diffusion-based and iontophoretic), controlled and sustained release back of the eye therapeutics for sight threatening diseases such as severe uveitis, diabetic macular edema and age-related macular degeneration. Aciont’s goal is to provide ophthalmologists substantially greater freedom in treating and/or preventing chronic eye diseases through optimal drug dosing and improved patient/physician compliance. Aciont is located in Salt Lake City, Utah.
|